Medical-products maker Cantel Medical announced Monday that its Mar Cor Purification subsidiary has purchased Siemens' hemodialysis water business, used in dialysis, for an undisclosed sum.

The business services 600 customers in the U.S. and Canada and generated about $9 million in revenue last year. Cantel is already a leader in the dialysis industry, providing "advanced heat-based disinfection" services to prevent and control infections.

Cantel says the purchase will further expand Mar Cor's "North American footprint" and will also be "slightly accretive" to earnings for the company in fiscal 2013. Shares of the company shed 0.6% of their value in Monday trading, closing at $29.03.

The article Cantel Medical Buying Siemens Sub originally appeared on Fool.com.

Fool contributor Rich Smith and The Motley Fool have no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.


Increase your money and finance knowledge from home

What is Short Selling?

Make a profit when stocks prices fall.

View Course »

Investor’s Toolbox

Improve your investing savvy with the right financial toolset.

View Course »

Add a Comment

*0 / 3000 Character Maximum